MAM
Jayesh Ravindranath joins Triton as executive director
MUMBAI: Triton Communications has announced the appointment of Jayesh Ravindranath as executive director, Triton Communications, Mumbai. He will assume office from 2 June. Prior to joining Triton, Ravindranath was senior VP at Lowe (Lintas).
Triton Communications director Ali Merchant said: “Jayesh brings a wealth of experience to his new assignment. His impressive background in brand management and strategic planning provide strength as we address the opportunities and challenges that await our business in the coming year.”
Ravindranath has worked with agencies such as Grey Worldwide (Singapore), J Walter Thompson (Middle East), Saatchi & Saatchi and Leo Burnett. He has over 20 years of brand building and marketing communications experience having worked on brands such as Unilever’s Clinic Plus, Omo, Lux and Organics, P&G’s Vicks, Whisper and Pantene, SmithKline Beecham’s Horlicks, Wrigleys, DeBeers, Citibank, Audi, Philips Domestic Appliances.
Ravindranath will fill in the shoes of Marzin R Shroff who spent seven years with the Triton Group. Shroff now moves on to join one of Triton’s clients Suashish Diamonds.
Formed 12 years ago, Triton Communications has grown into a Rs 2.5 billion group, by offering integrated marketing services to many clients in the industry like Eureka Forbes, Samsung India, Honda, Marico, Adani Wilmar, Triumph Distillers & Vintners, Bajaj Tempo (tractors), Dupont India, Outlook Magazine, Overnite Express, Uppal’s Orchid, Sanghi Cements and Zydus Cadila.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
